Research Progress on Oral Microbiota and Oral Cancer

Research Article
Open access

Research Progress on Oral Microbiota and Oral Cancer

Chunxi Yan 1*
  • 1 Department of Stomatology, North Sichuan Medical College, Nanchong, China    
  • *corresponding author yanchunxi2003@163.com
Published on 17 April 2025 | https://doi.org/10.54254/2753-8818/2025.22044
TNS Vol.99
ISSN (Print): 2753-8826
ISSN (Online): 2753-8818
ISBN (Print): 978-1-80590-007-8
ISBN (Online): 978-1-80590-008-5

Abstract

With the development of technology, although it has become easier to detect and treat oral cancer, it still causes significant harm to people’s lives. Therefore, it is urgent for researchers to clarify the mechanisms behind oral cancer and identify early detection signatures. Previous research has shown a connection between bacteria and the occurrence of cancer detected in other human organs, such as the intestinal tract and stomach. Subsequently, the potential principles of how oral bacteria increase the happening of oral cancer has attracted considerable interest from researchers. This article briefly introduces different signatures of oral bacteria in various human body conditions, such as variations in distribution and composition. Additionally, this passage summarizes the latest research results about the relationship between bacteria and the occurrence of oral cancer.

Keywords:

oral bacteria, oral squamous cell carcinoma, OSCC

Yan,C. (2025). Research Progress on Oral Microbiota and Oral Cancer. Theoretical and Natural Science,99,64-69.
Export citation

1. Introduction

About 30 trillion bacteria live inside or on the surface of each human body, which equals to approximately one bacterium for each cell. These bacteria constitute a complex and delicate ecosystem that fluctuates within the dynamic microenvironment, maintaining a symbiotic relationship with the human host. Human beings’ normal functions, such as digestion and immune response, cannot be maintained without bacteria. Furthermore, certain signatures presented by bacteria, such as composition and distribution, change as cancer progresses. Bacteria’s number in the mouth is small, accounting for just 1%, as previous reports have indicated; however, their concentrations should not be neglected (109 bacteria per mL in saliva and 10^11 bacteria per mL in dental plaque) [1,2]. Moreover, the diversion of oral bacteria ranks second in the human body, just behind the intestines, with around 700 species observed. A balance in oral bacteria contributes to physiological, metabolic, and immunological functions that help maintain homeostasis through the formation of a mucosal barrier. Recently, alterations in oral bacteria have been detected in many illnesses. It has been reported that the occurrence of oral squamous cell carcinoma (OSCC) is significantly associated with oral bacteria. As for malignant tumor in oral cavity, OSCC ranks the most, representing 2% of all tumors worldwide [3,4]. However, it is still unclear exactly how oral bacteria lead to the occurrence of OSCC, and further study and research are needed. This article focuses on the signatures of oral bacteria, including the distribution and composition of bacteria in healthy individuals, those with pre-existing lesions, and those diagnosed with OSCC. Current hypotheses regarding the effect of oral bacteria to the occurrence of OSCC are discussed, containing the stimulation of excessive inflammatory reactions, inhibition of apoptosis, promotion of tumor cell invasion, and emission of carcinogenic substances. Additionally, the related mechanisms are introduced and explained.

2. Healthy Oral Bacteria

Bacteria migrate to the oral cavity at a very early stage. With various species of bacteria living in such a small space, the environment of the oral cavity is quite complicated. Early in the fetal period, bacteria are transferred between the mother and infant at the foeto-maternal interface. Bacteria in the human body develop and gradually distribute to different parts after birth. The oral cavity creates a perfect living condition for bacteria, which has a moderate pH of 6.5–7 and an average temperature of 37°C. Various places in oral cavity all provide suitable conditions for bacteria to grow. Particularly, the extracellular polymeric matrix (EPM), known as biofilm in the oral cavity, is composed of polysaccharides, proteins, lipids, and extracellular DNA (eDNA). Up to 95% of bacteria live in biofilms, creating a highly active and complex ecosystem. Because the oral cavity has continuous exposure to the external environment, these bacteria change dynamically. However, most of the time, the bacterial composition is stable, with only slight fluctuations [4]. According to previous reports, the most common bacterial species include Streptococcus, Gemella, Eubacterium, Selenomonas, Veillonella, Actinomyces, Atopobium, Rothia, Neisseria, Eikenella, Campylobacter, Porphyromonas, Prevotella, Granulicatella, Capnocytophaga, Fusobacterium, Leptotrichia, and Streptococcus mitis [5]. These can be classified into six main phyla: Actinobacteria, Bacteroidetes, Firmicutes, Fusobacteria, Proteobacteria, and Spirochaetes [4]. Due to different structures and environments, bacterial categories and concentrations vary across multiple oral sites. Additionally, the distribution and composition of bacteria also have association with factors such as physiological conditions, geographical location, and racial characteristics [2]. These complex ecosystems play important roles in normal human activities. For example, these bacteria work harmoniously to ensure that human body could steadily assimilate nutrients such as sugars and protein. Glycosidic enzymes are indispensable parts in these processes, which are produced by bacteria, such as sialidase, N-acetylglucosaminidases, β-galactosidase, mannosidases, α-fucosidase, exo-proteolytic, and endo-proteolytic activities [6]. These bacteria also help keep oral state of cleanness by reducing pathogens’ adherence to the mucosal surface. This role is facilitated by bacteria emitting Immunoglobulin A (IgA), the dominant class of antibodies in the gastrointestinal mucosa, which is a key component of the gastrointestinal barrier [7].

3. The Oral Bacteria and Oral Cancer

The composition and distribution of oral bacteria vary significantly as people’s health conditions change (Table 1). When internal or external factors cause the imbalance of bacteria in the oral cavity, dysbiosis occurs. According to previous research, these abnormalities are directly linked to OSCC. Oral leukoplakia, which shows symptoms of having a white spot on the oral mucosa, is regarded as the most common pre-existing lesion with malignant potential for OSCC. AMER A et al. compared the bacterial composition between oral leukoplakia tissue and healthy mucosal tissue from the same patient to identify early markers of malignant progression. The results show that, compared with contralateral normal sites, leukoplakia samples have higher levels of Proteobacteria and Fusobacteria and lower levels of Firmicutes. Additionally, nearly 35% of samples from leukoplakia sites are colonized by Candida spp. [8]. Lee et al. studied bacterial differences between normal individuals, patients with epithelial precursor lesions, and cancer patients. Results show that the dominant bacterial species belonged to one of five phyla: Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, and Fusobacteria. These phyla were present consistently in all individuals. However, the abundance of Megasphaera, Escherichia, and Atopobium differed among three groups mentioned above. Contrasted with the normal group, the abundance of Blautia, Dorea, Faecalibacterium, and Phascolarctobacterium increased in the epithelial precursor lesion group. Additionally, there was a huge increase in the abundance of Bacteroides, Escherichia, Cloacibacillus, Gemmiger, Oscillospira, and Roseburia in samples having epithelial precursor lesion and cancer [9]. Cancer progression has been divided into four phases based on the degree of severity. Yang et al. compared samples from individuals in healthy conditions and patients in different phases of OSCC. They found that the quantity of Fusobacteria increased largely as oral cancer progressed from the healthy controls (2.98%) to OSCC stage 1 (4.35%) and stage 4 (7.92%). At the genus level, Fusobacterium periodonticum, Parvimonas, Streptococcus constellatus, Haemophilus influenzae, and Filifactor alocis have connection with OSCC, and their quantities gradually increased from phase 1 to phase 4. However, the quantities of Streptococcus mitis, Haemophilus parainfluenzae, and Porphyromonas pasteri show inverse relationship with the development of OSCC [10].

Table 1: Variations of Predominant Bacteria Found in Oral Cancer.

Name

Absolute Quantitative Variations in Oral Cancer

Name

Absolute Quantitative Variations in Oral Cancer

Bacteroides

Elevated

Escherichia

Elevated

Cloacibacillus

Elevated

Gemmiger

Elevated

Oscillospira

Elevated

Roseburia

Elevated

Fusobacterium periodonticum

Elevated

Parvimonas

Elevated

Streptococcus constellatus

Elevated

Haemophilus parainfluenzae

Reduced

Filifactor alocis

Elevated

Streptococcus mitis

Reduced

Haemophilus influenza

Elevated

Porphyromonas pasteri

Reduced

4. Mechanism

The mechanism by which bacterial dysbiosis induces the development of OSCC has been studied for a long time. During bacterial dysbiosis, substances from the bacteria themselves or emitted by the bacteria can stimulate diverse responses in the host, which may lead to OSCC (Table 2).

4.1. Excessive Inflammation

Angiogenesis, tumor progression, and metastasis are all linked to inflammation caused by infection. Oral dysbiosis may facilitate the development of both local and systemic inflammation, which can be exacerbated by inflammation, thus resulting in a vicious cycle. Flagella on the surface of bacteria and cytotoxins (e.g., ExoU) are strongly associated with OSCC-related inflammation. Bacterial endotoxins released by gram-negative bacteria can activate pattern recognition receptors (PRRs) such as TLRs (particularly TLR4). These can activate signaling pathways which cause inflammation such as nuclear factor kappa B (NF-kB), Wnt, and JAK-STAT3 cascades, which extend the influence of bacteria on cancer development. The inflammatory response also involves various cytokines such as interleukin‐1β (IL‐1β), IL‐6, tumor necrosis factor-α (TNF-α), and matrix metalloproteinases MMP‐9. Among these, IL‐1β has attracted significant attention. IL‐1β can cause inflammation by activating osteoclast formation and activating endothelial cells to excrete vascular endothelial growth factor (VEGF) and other proangiogenic factors (e.g., TNF). IL-1β also acts as a promoter of inflammation due to its ability to release TNF and IL-6. IL-6 leads bone to resorb and causes generations of acute-phase proteins, chemokines, and PGE2. IL-6 could cause oxidative stress and significant H2O2 accumulation in mitochondria, causing mitochondrial trauma. Mitochondria are indispensable organelles for most eukaryotic cells, and the mitochondrial genome has high relevance with carcinogenesis and cancer metastasis. Increased contents of reactive oxygen species (ROS) and stabilization of hypoxia-inducible factor-1 (HIF-1) are associated with mutations in the mitochondrial genome. These variations in both coding and noncoding areas, could accelerate tumorigenicity, cell motility, and metastasis. Low concentrations of bacteria-induced TNF-α have been reported to be associated with tumor promotion. TNF-α is a key cytokine in the process of generating reactive oxygen species (ROS), leukotrienes, prostaglandins, and metalloproteinases, which can damage DNA and have been shown to be linked to cancer progression. Additionally, osteogenic cells and fibroblasts significantly decrease, primarily due to TNF-α [11–13].

4.2. Inhibition of Apoptosis

Cancer cells’ ability to inhibit apoptosis can lead to long-term proliferation and chemoresistance. Porphyromonas gingivalis (P. gingivalis) has been shown to participate in inhibiting apoptosis in host cells and then lead to the occurrence of cancer. Research suggests that P. gingivalis might exert its effect by stimulating the JAK1/STAT3 and PI3K/Akt signaling pathways in epithelial cells. These pathways regulate intrinsic mitochondrial apoptosis processes [14]. Jungnam Lee et al. found that a homologue of the conserved nucleoside-diphosphate kinase (Ndk) family of multifunctional enzymes, secreted by P. gingivalis, can regulate specific host molecular pathways, then bring variations such as less synthesis of reactive oxygen species (ROS). Lower concentration of ROS could enable bacterial survive in human gingival epithelial cells (GECs). By comparing P. gingivalis-Ndk protein constructs with an isogenic P. gingivalis-Ndk-deficient mutant strain, they observed that P. gingivalis-infected GECs show rising levels of phospho-heat-shock protein 27 (HSP27) compared with the Ndk-deficient strain. Thus, they concluded that P. gingivalis inhibits host cell apoptosis by HSP27 [15].

4.3. Promotion of Tumor Cell Invasion

Tumor cells can also activate key pathways to release substances that damage human tissue, thereby facilitating invasion. Suchitra Singh et al. found that P. gingivalis can promote tumor cell invasion. Their results show that pathways such as ERK 1/2–Ets1, p38/HSP27, and PAR2/NF-κB are stimulated after P. gingivalis’ infection. The extracellular signal-regulated kinase 1/2 (ERK1/2) pathway has been shown to be associated with tumors. It can elevate the invasive and metastatic capabilities of cancer cells, equip cancer cells with the ability to resist chemotherapy and radiation, and regulate tumorigenic potential by maintaining cancer stem cells. E26 transformation-specific (Ets) transcription family members take part in various biological processes, including tumor-causing transformation, angiogenesis, differentiation, and apoptosis. Ets1 can be activated by Ets transcription factors, which are downstream of ERK1/2. P38 is a multifunctional kinase that regulates various cellular functions. It has effect in cell proliferation, differentiation, stress response, apoptosis, and cell migration and survival. It has been shown to be associated with tumor occurrence. Protease-activated receptor 2 (PAR2) is a G protein-coupled receptor (GPCR) that is primarily activated by trypsin-like serine proteases to start signal transduction pathways (Ca2+ release, ERK1/2 phosphorylation, RhoA activation, cAMP down-regulation, and β-arrestin1/2 recruitment), which mediate both physiological and pathological processes, such as cancer. The activation of these pathways leads to the generation of matrix metalloproteinases (MMP-9). P. gingivalis also synthesis gingipains and cysteine proteinases, which can degrade the basement membrane and extracellular matrix, allowing tumor cells to enter the systema lymphaticum and blood vessels. In this way, it enables tumor cells to spread further, accelerating cancer progression [16,17].

4.4. Production of Carcinogenic Substances

Additionally, bacteria can generate other substances with carcinogenic effects. Bacteria such as Lactobacillus, Lactococcus, Bifidobacterium, Streptococcus, Leuconostoc, and Pediococcus can produce lactic acid. Lactic acid, such as lactate, is associated with cancer development, maintenance, and metastasis. Tumor cells can utilize lactate as an energy source and transport it to nearby cancer cells, close stroma, and vascular endothelial cells, which induces reprogramming in metabolism. High concentrations of lactic acid in the tumor microenvironment can also block lactate export in T cells, thereby destroying their proper physiologic function. Mark R. Hellmich et al. found that there is an obvious increasing expression of various hydrogen sulfide (H2S)-producing enzymes in cancer cells no matter the type of tissue. H2S can enhance tumor development and diffusion by boosting cellular bioenergetics, activating pathways in proliferation, migration, and invasion, and strengthen tumor angiogenesis [13].

Table 2: Pathways and Substances Mentioned in Different Hypotheses.

Hypothesis

Pathway

Substance

Excessive Inflammation

Nuclear factor-κB (NF-κB)

Wnt

JAK-STAT3

flagella

cytotoxins (ExoU)

endotoxins

IL‐1β, IL‐6

tumor necrosis factor-α (TNF-α)

matrix metalloproteinases MMP‐9

vascular endothelial growth factor (VEGF)

proangiogenic factors (TNF)

acute phase proteins

chemokines

PGE2

H2O2

oxygen compounds (ROS)

leukotrienes

prostaglandins

metalloproteinases

Inhibition of Apoptosis

JAK1/STAT3

PI3K/Akt

phospho-heat-shock protein 27 (HSP27)

Promotion of Tumor Cells’ Invasion

ERK 1/2‑Ets 1

p38/HSP27

PAR2/NF‑ΚB

Ets 1

p38

protease-activated receptor 2 (PAR2)

matrix metalloproteinases MMP‑9

gingipains

cysteine proteinases

Production of Carcinogenic Substances

lactic acid (lactate)

H2S

5. Conclusion

Bacteria are indispensable to human beings. Under healthy conditions, bacteria participate in many physiological activities of the human body. The composition and distribution change when the balance is disrupted in the oral cavity. Bacterial variations in the oral cavity have obvious effect in the occurrence of OSCC. It is hypothesized that this leads to cancer through four mechanisms: (1) excessive inflammation; (2) inhibition of apoptosis; (3) promotion of tumor cell invasion; and (4) production of carcinogenic substances. However, further research is needed to determine the exact mechanisms behind the occurrence of OSCC.


References

[1]. SENDER R, FUCHS S, MILO R. Revised Estimates for the Number of Human and Bacteria Cells in the Body[J/OL]. PLoS biology, 2016, 14(8): e1002533. DOI:10.1371/journal.pbio.1002533.

[2]. PIGNATELLI P, ROMEI F M, BONDI D, Microbiota and Oral Cancer as A Complex and Dynamic Microenvironment: A Narrative Review from Etiology to Prognosis[J/OL]. International Journal of Molecular Sciences, 2022, 23(15): 8323. DOI:10.3390/ijms23158323.

[3]. DI STEFANO M, SANTONOCITO S, POLIZZI A, . A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation[J/OL]. International Journal of Molecular Sciences, 2023, 24(2): 1084. DOI:10.3390/ijms24021084.

[4]. TALAPKO J, ERIĆ S, MEŠTROVIĆ T, . The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer[J/OL]. Cancers, 2024, 16(17): 2997. DOI:10.3390/cancers16172997.

[5]. SHAILAJA T S, SATHIAVATHY K A, UNNI G. Infective endocarditis caused by Granulicatella adiacens[J/OL]. Indian Heart Journal, 2013, 65(4): 447-449. DOI:10.1016/j.ihj.2013.06.014.

[6]. ROWLAND I, GIBSON G, HEINKEN A, . Gut microbiota functions: metabolism of nutrients and other food components[J/OL]. European Journal of Nutrition, 2018, 57(1): 1-24. DOI:10.1007/s00394-017-1445-8.

[7]. ŠTŠEPETOVA J, TRUU J, RUNNEL R, . Impact of polyols on Oral microbiome of Estonian schoolchildren[J/OL]. BMC oral health, 2019, 19(1): 60. DOI:10.1186/s12903-019-0747-z.

[8]. AMER A, GALVIN S, HEALY C M, . The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species[J/OL]. Frontiers in Microbiology, 2017, 8: 2391. DOI:10.3389/fmicb.2017.02391.

[9]. LEE W H, CHEN H M, YANG S F, . Bacterial alterations in salivary microbiota and their association in oral cancer[J/OL]. Scientific Reports, 2017, 7(1): 16540. DOI:10.1038/s41598-017-16418-x.

[10]. YANG C Y, YEH Y M, YU H Y, . Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging[J/OL]. Frontiers in Microbiology, 2018, 9: 862. DOI:10.3389/fmicb.2018.00862.

[11]. SUN J, TANG Q, YU S, 等. Role of the oral microbiota in cancer evolution and progression[J/OL]. Cancer Medicine, 2020, 9(17): 6306-6321. DOI:10.1002/cam4.3206.

[12]. CHATTOPADHYAY I, VERMA M, PANDA M. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer[J/OL]. Technology in Cancer Research & Treatment, 2019, 18: 1533033819867354. DOI:10.1177/1533033819867354.

[13]. KARPIŃSKI T M. Role of Oral Microbiota in Cancer Development[J/OL]. Microorganisms, 2019, 7(1): 20. DOI:10.3390/microorganisms7010020.

[14]. PERERA M, AL-HEBSHI N N, SPEICHER D J, . Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria[J/OL]. Journal of Oral Microbiology, 2016, 8: 32762. DOI:10.3402/jom.v8.32762.

[15]. LEE J, ROBERTS J S, ATANASOVA K R, . A novel kinase function of a nucleoside-diphosphate-kinase homologue in Porphyromonas gingivalis is critical in subversion of host cell apoptosis by targeting heat-shock protein 27[J/OL]. Cellular Microbiology, 2018, 20(5): e12825. DOI:10.1111/cmi.12825.

[16]. DEO P N, DESHMUKH R. Oral microbiome and oral cancer - The probable nexus[J/OL]. Journal of oral and maxillofacial pathology: JOMFP, 2020, 24(2): 361-367. DOI:10.4103/jomfp.JOMFP_20_20.

[17]. SINGH S, YADAV P K, SINGH A K. In-silico structural characterization and phylogenetic analysis of Nucleoside diphosphate kinase: A novel antiapoptotic protein of Porphyromonas gingivalis[J/OL]. Journal of Cellular Biochemistry, 2023, 124(4): 545-556. DOI:10.1002/jcb.30389.


Cite this article

Yan,C. (2025). Research Progress on Oral Microbiota and Oral Cancer. Theoretical and Natural Science,99,64-69.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 5th International Conference on Biological Engineering and Medical Science

ISBN:978-1-80590-007-8(Print) / 978-1-80590-008-5(Online)
Editor:
Conference website: https://2025.icbiomed.org/
Conference date: 17 October 2025
Series: Theoretical and Natural Science
Volume number: Vol.99
ISSN:2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).

References

[1]. SENDER R, FUCHS S, MILO R. Revised Estimates for the Number of Human and Bacteria Cells in the Body[J/OL]. PLoS biology, 2016, 14(8): e1002533. DOI:10.1371/journal.pbio.1002533.

[2]. PIGNATELLI P, ROMEI F M, BONDI D, Microbiota and Oral Cancer as A Complex and Dynamic Microenvironment: A Narrative Review from Etiology to Prognosis[J/OL]. International Journal of Molecular Sciences, 2022, 23(15): 8323. DOI:10.3390/ijms23158323.

[3]. DI STEFANO M, SANTONOCITO S, POLIZZI A, . A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation[J/OL]. International Journal of Molecular Sciences, 2023, 24(2): 1084. DOI:10.3390/ijms24021084.

[4]. TALAPKO J, ERIĆ S, MEŠTROVIĆ T, . The Impact of Oral Microbiome Dysbiosis on the Aetiology, Pathogenesis, and Development of Oral Cancer[J/OL]. Cancers, 2024, 16(17): 2997. DOI:10.3390/cancers16172997.

[5]. SHAILAJA T S, SATHIAVATHY K A, UNNI G. Infective endocarditis caused by Granulicatella adiacens[J/OL]. Indian Heart Journal, 2013, 65(4): 447-449. DOI:10.1016/j.ihj.2013.06.014.

[6]. ROWLAND I, GIBSON G, HEINKEN A, . Gut microbiota functions: metabolism of nutrients and other food components[J/OL]. European Journal of Nutrition, 2018, 57(1): 1-24. DOI:10.1007/s00394-017-1445-8.

[7]. ŠTŠEPETOVA J, TRUU J, RUNNEL R, . Impact of polyols on Oral microbiome of Estonian schoolchildren[J/OL]. BMC oral health, 2019, 19(1): 60. DOI:10.1186/s12903-019-0747-z.

[8]. AMER A, GALVIN S, HEALY C M, . The Microbiome of Potentially Malignant Oral Leukoplakia Exhibits Enrichment for Fusobacterium, Leptotrichia, Campylobacter, and Rothia Species[J/OL]. Frontiers in Microbiology, 2017, 8: 2391. DOI:10.3389/fmicb.2017.02391.

[9]. LEE W H, CHEN H M, YANG S F, . Bacterial alterations in salivary microbiota and their association in oral cancer[J/OL]. Scientific Reports, 2017, 7(1): 16540. DOI:10.1038/s41598-017-16418-x.

[10]. YANG C Y, YEH Y M, YU H Y, . Oral Microbiota Community Dynamics Associated With Oral Squamous Cell Carcinoma Staging[J/OL]. Frontiers in Microbiology, 2018, 9: 862. DOI:10.3389/fmicb.2018.00862.

[11]. SUN J, TANG Q, YU S, 等. Role of the oral microbiota in cancer evolution and progression[J/OL]. Cancer Medicine, 2020, 9(17): 6306-6321. DOI:10.1002/cam4.3206.

[12]. CHATTOPADHYAY I, VERMA M, PANDA M. Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer[J/OL]. Technology in Cancer Research & Treatment, 2019, 18: 1533033819867354. DOI:10.1177/1533033819867354.

[13]. KARPIŃSKI T M. Role of Oral Microbiota in Cancer Development[J/OL]. Microorganisms, 2019, 7(1): 20. DOI:10.3390/microorganisms7010020.

[14]. PERERA M, AL-HEBSHI N N, SPEICHER D J, . Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria[J/OL]. Journal of Oral Microbiology, 2016, 8: 32762. DOI:10.3402/jom.v8.32762.

[15]. LEE J, ROBERTS J S, ATANASOVA K R, . A novel kinase function of a nucleoside-diphosphate-kinase homologue in Porphyromonas gingivalis is critical in subversion of host cell apoptosis by targeting heat-shock protein 27[J/OL]. Cellular Microbiology, 2018, 20(5): e12825. DOI:10.1111/cmi.12825.

[16]. DEO P N, DESHMUKH R. Oral microbiome and oral cancer - The probable nexus[J/OL]. Journal of oral and maxillofacial pathology: JOMFP, 2020, 24(2): 361-367. DOI:10.4103/jomfp.JOMFP_20_20.

[17]. SINGH S, YADAV P K, SINGH A K. In-silico structural characterization and phylogenetic analysis of Nucleoside diphosphate kinase: A novel antiapoptotic protein of Porphyromonas gingivalis[J/OL]. Journal of Cellular Biochemistry, 2023, 124(4): 545-556. DOI:10.1002/jcb.30389.